News & Press Releases


Keep up with the latest news from Anocca

Press releases

Anocca appoints Jacob Michlewicz as CFO

Södertälje, Sweden, 8 September 2021 – Anocca AB, a leader in unlocking the potential of T-cell immunotherapy to deliver transformative therapeutics, today announced the appointment of Jacob Michlewicz as Chief Financial Officer, effective immediately, and based at...

Anocca utser Jacob Michlewicz till CFO

Södertälje, 8 september 2021 – Anocca AB, ett världsledande svenskt bioteknikbolag för utveckling av T-cellsbehandlingar mot cancer, autoimmuna sjukdomar och virusinfektioner, tillkännagav idag utnämningen av Jacob Michlewicz till CFO, med omedelbar verkan. Han är...

Anocca in the news

Anocca: Standardizing TCR cell therapy design

Originally published in BioCentury. Anocca is using engineered human cells to recapitulate the T cell immune system ex vivo, eliminating the person-to-person variability in working with primary T cells from patients, to create standardized, scalable TCR-modified T...

Reports & Regulatory press releases